European Commission Approves Pfizer’s PREVENAR 20
Pfizer Inc. has announced that the European Commission (EC) has granted marketing authorization for the company’s 20-valent pneumococcal conjugate vaccine, marketed in the European Union under the brand name PREVENAR 20®, for active immunization for the prevention of invasive disease, pneumonia and acute otitis media caused by Streptococcus pneumoniae in infants, children and adolescents from […]
European Commission Approves Pfizer’s PREVENAR 20 Read More »